NSETrading Window55m ago · 25 Sept 2026, 05:43 pm

Trading Window

Solara Active Pharma Sciences Limited · SOLARA

✦ AI Summary

Solara Active Pharma Sciences Limited has informed the Exchange regarding the closure of the trading window due to the SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

SOLARA_25092026174212_SE_Letter_final.pdf

pdf

Download →
View document text
Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: September 25, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Intimation regarding closure of Trading Window In accordance with the Company’s Code of Conduct for Prohibition of Insider Trading and in compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT Regulations”) the Trading Window for dealing in the securities of the Company shall be closed with effect from Thursday, October 1, 2026, till 48 hours from the date of declaration of financial results of the Company for the quarter and half year ending September 30, 2026. The date of Board Meeting for declaration of financial results of the Company for the quarter and half year ending September 30, 2026 will be intimated in due course. We request you to take the above information on your records. Thanking You, Yours Faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No: A57415 Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91- 22-20870033